Skip to main content

Concise Review: Process Development Considerations for Cell Therapy.

Publication ,  Journal Article
Campbell, A; Brieva, T; Raviv, L; Rowley, J; Niss, K; Brandwein, H; Oh, S; Karnieli, O
Published in: Stem cells translational medicine
October 2015

The development of robust and well-characterized methods of production of cell therapies has become increasingly important as therapies advance through clinical trials toward approval. A successful cell therapy will be a consistent, safe, and effective cell product, regardless of the cell type or application. Process development strategies can be developed to gain efficiency while maintaining or improving safety and quality profiles. This review presents an introduction to the process development challenges of cell therapies and describes some of the tools available to address production issues. This article will provide a summary of what should be considered to efficiently advance a cellular therapy from the research stage through clinical trials and finally toward commercialization. The identification of the basic questions that affect process development is summarized in the target product profile, and considerations for process optimization are discussed. The goal is to identify potential manufacturing concerns early in the process so they may be addressed effectively and thus increase the probability that a therapy will be successful.The present study contributes to the field of cell therapy by providing a resource for those transitioning a potential therapy from the research stage to clinical and commercial applications. It provides the necessary steps that, when followed, can result in successful therapies from both a clinical and commercial perspective.

Duke Scholars

Published In

Stem cells translational medicine

DOI

EISSN

2157-6580

ISSN

2157-6564

Publication Date

October 2015

Volume

4

Issue

10

Start / End Page

1155 / 1163

Related Subject Headings

  • Translational Research, Biomedical
  • Technology Transfer
  • Risk Assessment
  • Research Design
  • Product Packaging
  • Peripheral Arterial Disease
  • Models, Theoretical
  • Manufacturing Industry
  • Industrial Development
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Campbell, A., Brieva, T., Raviv, L., Rowley, J., Niss, K., Brandwein, H., … Karnieli, O. (2015). Concise Review: Process Development Considerations for Cell Therapy. Stem Cells Translational Medicine, 4(10), 1155–1163. https://doi.org/10.5966/sctm.2014-0294
Campbell, Andrew, Thomas Brieva, Lior Raviv, Jon Rowley, Knut Niss, Harvey Brandwein, Steve Oh, and Ohad Karnieli. “Concise Review: Process Development Considerations for Cell Therapy.Stem Cells Translational Medicine 4, no. 10 (October 2015): 1155–63. https://doi.org/10.5966/sctm.2014-0294.
Campbell A, Brieva T, Raviv L, Rowley J, Niss K, Brandwein H, et al. Concise Review: Process Development Considerations for Cell Therapy. Stem cells translational medicine. 2015 Oct;4(10):1155–63.
Campbell, Andrew, et al. “Concise Review: Process Development Considerations for Cell Therapy.Stem Cells Translational Medicine, vol. 4, no. 10, Oct. 2015, pp. 1155–63. Epmc, doi:10.5966/sctm.2014-0294.
Campbell A, Brieva T, Raviv L, Rowley J, Niss K, Brandwein H, Oh S, Karnieli O. Concise Review: Process Development Considerations for Cell Therapy. Stem cells translational medicine. 2015 Oct;4(10):1155–1163.

Published In

Stem cells translational medicine

DOI

EISSN

2157-6580

ISSN

2157-6564

Publication Date

October 2015

Volume

4

Issue

10

Start / End Page

1155 / 1163

Related Subject Headings

  • Translational Research, Biomedical
  • Technology Transfer
  • Risk Assessment
  • Research Design
  • Product Packaging
  • Peripheral Arterial Disease
  • Models, Theoretical
  • Manufacturing Industry
  • Industrial Development
  • Humans